Completed OBSERVATIONAL NCT03633838

Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China (CONTAIN)

Clinical Outcome of Corticosteroids in the Treatment of Chronic Obstructive Pulmonary Disease(COPD) Exacerbations in China (CONTAIN Study): Post-hoc Analysis of the Database of Acute Exacerbation of COPD Non-interventional Study

Sponsor: AstraZeneca

Conditions Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Updated 5 times since 2018 Last updated: Sep 13, 2018 Started: Feb 28, 2017 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Exacerbation of Chronic Obstructive Pulmonary Disease, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2018 — Jan 2021 [monthly]

Completed
Sep 2018 — Oct 2018 [monthly]

Completed

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China